Mankind Pharma LimitedShare price targets & analyst calls
₹2,465-15.00 (-0.60%)
Analysts lean BUY·8 of 9 long-term calls BUY·consensus 1Y target ₹2,771.44 (12.4% above CMP)
₹2,771.44
12.4% above CMP
₹2,080 – ₹3,220
9 active 1Y targets
13 open
12 BUY · 1 SELL (all horizons)
25%
10 of 40 closed calls hit
Watch MANKIND for new buy/sell callsGet alertsSee 58 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips · page 2 of 2
BUYMANKINDMankind PharmaHorizon: Intraday* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI5+·0−-1.01% realisedNA upside left
SL
₹2,388
Entry*
₹2,412.4
Target
₹2,450
hit 19 Aug 2026, 12:47 pm
PGPrakash Gaba· via CNBC Awaaz.5w ago
BUYMANKINDMankind PharmaHorizon: Intraday* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-1.02% realisedNA upside left
SL
₹2,520
Entry*
₹2,546
Target
₹2,590
hit 1 Jul 2026, 9:42 am
PGPrakash Gaba· via CNBC Awaaz.12w ago
BUYMANKINDMankind PharmaHorizon: Intraday* (horizon not stated by the source; assumed from the target's distance)Expired
AI4+·0−-0.05% realisedNA upside left
₹2,390.9
At expiry
SL
₹2,380
Entry*
₹2,392.1
Target
₹2,450
expired 19 Aug 2026, 3:05 pm
RSRajesh Satpute· via CNBC Awaaz.5w ago
+0.74% realisedNA upside left
₹2,407.7
At expiry
SL
₹2,368
Entry
₹2,390
Target
₹2,456
expired 18 Jun 2026, 3:20 pm
AKArun Kumar Mantri· via CNBC Awaaz.13w ago
Showing 51–55 of 55